Johnson, William

Publications

Sort by

Co-Author Network

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 61
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization. Cancer research. 2013 Academic Article GET IT
Times cited: 75
Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer research. 2011 Academic Article GET IT
Times cited: 60
Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. European journal of endocrinology. 2010 Academic Article GET IT
Times cited: 36